Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006-18: prospective observational time-series and case-control studies
Summary: Background: The population impact of pneumococcal conjugate vaccines (PCVs) depends on direct and indirect protection. Following Malawi's introduction of the 13-valent PCV (PCV13) in 2011, we examined its impact on vaccine and non-vaccine serotype invasive pneumococcal disease among va...
Saved in:
Main Authors: | Naor Bar-Zeev, PhD (Author), Todd D Swarthout, MSc (Author), Dean B Everett, ProfPhD (Author), Maaike Alaerts, PhD (Author), Jacquline Msefula, BSc (Author), Comfort Brown, Dipl (Author), Sithembile Bilima, BSc (Author), Jane Mallewa, MD (Author), Carina King, PhD (Author), Anne von Gottberg, ProfPhD (Author), Jennifer R Verani, MD (Author), Cynthia G Whitney, MD (Author), Charles Mwansambo, FRCPCH (Author), Stephen B Gordon, ProfPhD (Author), Nigel A Cunliffe, ProfPhD (Author), Neil French, ProfPhD (Author), Robert S Heyderman, ProfPhD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis
by: Tinevimbo Shiri, DrPhD, et al.
Published: (2017) -
Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines
by: Miquel Oliu-Barton, PhD, et al.
Published: (2022) -
Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis
by: Cynthia Chen, PhD, et al.
Published: (2019) -
Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data
by: Dongshan Zhu, MD, et al.
Published: (2019) -
Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial
by: Daniel Freeman, ProfPhD, et al.
Published: (2021)